Tennessee § 53-14-104 License - Required - Application - Fees

Tennessee Statutes

§ 53-14-104 — License - Required - Application - Fees

Tennessee § 53-14-104

Title53

This text of Tennessee § 53-14-104 (License - Required - Application - Fees) is published on Counsel Stack Legal Research, covering Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tenn. Code Ann. § 53-14-104 (2026).

Text

(a)No person shall manufacture, obtain, possess, administer or dispense a legend drug, controlled substance or controlled substance analogue for the purpose of scientific research, chemical analysis, instruction or training of detection animals without having first secured a license to do so from the director.

(b)An application for the license shall be submitted on the prescribed form, and shall be accompanied by:

(1)A nonrefundable fee of thirty dollars ($30.00), or in an amount set by the board;

(2)Copies of all papers and materials filed with any state or federal governmental agency in connection with the applicant's proposed project; and (3) A detailed protocol, in triplicate, setting forth:

(A)The nature of the proposed project;

(B)The qualifications of the applicant to engage i

Free access — add to your briefcase to read the full text and ask questions with AI

(a) No person shall manufacture, obtain, possess, administer or dispense a legend drug, controlled substance or controlled substance analogue for the purpose of scientific research, chemical analysis, instruction or training of detection animals without having first secured a license to do so from the director. (b) An application for the license shall be submitted on the prescribed form, and shall be accompanied by: (1) A nonrefundable fee of thirty dollars ($30.00), or in an amount set by the board; (2) Copies of all papers and materials filed with any state or federal governmental agency in connection with the applicant's proposed project; and (3) A detailed protocol, in triplicate, setting forth: (A) The nature of the proposed project; (B) The qualifications of the applicant to engage in the project; (C) The proposed quantity of each drug involved; (D) The measures proposed to provide for security and proper record-keeping of the drugs; (E) Specific provisions for the safe administration or dispensing of drugs to humans, if contemplated, and the proposed method for selecting the humans; and (F) Other information the commissioner may require.